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System Set-up and Parameterisation  
OXA-48 with ceftazidime was originally set-up using OXA-48 acylenzyme structure with imipenem 
as the template (PDB:5QB4)1, and by replacing imipenem with ceftazidime as found in OXA-225 
K82D structure (PDB: 4X55)2. Upon the publication of OXA-48 P68A with ceftazidime crystal 
structure (PDB: 6Q5F),3 further models were built based on the new binding pose of ceftazidime 
either by taking the new binding pose and combining it with the protein structure used with the first 
model (with the Ω-loop and β5-β6 loops as found in the apoenzyme), or by mutating the new crystal 
structure back to the wild-type enzyme and reconstructing the Ω-loop in a disordered state using 
Modeller (described below). For OXA-163 models, the apoenzyme crystal structure (PDB: 4S2L)4 
was used with both CTZ binding poses. For OXA-181, four residues were mutated with respect to the 
OXA-48 model, all mutations were performed using the mutagenesis wizard in PyMol (OXA-181 and 
OXA-48 Arg214Ser). DW was manually added to the active site for all models, and all 
crystallographic water molecules were kept excluding the ones clashing with the acylenzyme (closer 
than 2.5 Å from any acylenzyme atom). Carboxylated lysine (Lys73) was kept as found in the OXA-
48 and imipenem structure, which is essentially the same as in the OXA-48 apoenzyme structure 
(PDB: 4S2P)5. To avoid any possible steric clashes between the acylenzyme and the rest of the 
protein, Arg214 was rotated towards bulk solvent in all starting structures. All starting structures are 
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available to download from Supporting Information as a zip file. Ceftazidime in the acylenzyme was 
modelled without the pyridine ring, as its elimination has been observed experimentally.6  
Protonation states of titratable residues were determined using PropKa3.1.7, 8 Based on the predicted 
pKa values, all titratable residues were kept in their default state (all Glu/Asp deprotonated, all Lys 
protonated). Histidine tautomers were predicted using reduce as implemented in the Amber program 
package (all histidines were singly protonated, are solvent exposed and distant from the active site). 
Hydrogen atoms were then added and all systems were solvated in a 10 Å box of TIP3P water using 
tLeap, with overall charge neutralized by replacing bulk water molecules with Na+ ions. The ff14SB 
force field was used to describe the protein, and the TIP3P compatible parameters were used for the 
counterions.9 Charge parametrization for non-standard residues (carboxylated lysine, KCX, and 
ceftazidime acylenzyme, CTZ – without the pyridine ring) was done using restrained electrostatic 
potential (RESP) fitting as implemented in the RED Server.10 Missing force field parameters were 
taken from analogous GAFF parameters.11 Parameter files for both fragments are available as part of 
the Supporting information zip file. 
 
Figure S1. Different models built for OXA-48 and OXA-163 with ceftazidime.  A. OXA-48 with Ω-
loop as found in the apoenzyme and ceftazidime binding pose as in the OXA-48 and ceftazidime 
crystal structure (binding pose 1). B. OXA-48 with Ω-loop as found in the apoenzyme and ceftazidime 
binding pose as in the OXA-225 and ceftazidime complex (binding pose 2). C. OXA-48 with a 
disordered Ω-loop built using MODELLER and ceftazidime binding pose as in the OXA-48 and 
ceftazidime complex. D. OXA-163 and ceftazidime binding pose as in the OXA-48 and ceftazidime 
crystal structure (binding pose 1). E. OXA-163 and ceftazidime binding pose as in the OXA-225 and 
ceftazidime structure (binding pose 2). 
 
Loop Generation 
In the OXA-48 structure complexed with CTZ (PDB ID: 6Q5F),3 electron density was not found for 
residues between Asp148 and Ile162 (ISGNVDSFWLDGGIR, 13 residue gap). 250 new models for 
the “disordered” Ω-loop were reconstructed using MODELLER12 with slow loop refinement, whilst 
the rest of the atoms in the apoenzyme were kept fixed. (KCX was mutated back to lysine and CTZ 
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removed for model generation to avoid parameter problems with non-standard residues.) Models were 
initially inspected using both the DOPE and molpdf scores, and 25 models were chosen for visual 
inspection (all models were in the top 50 for at least one scoring method, emphasis was given for 
DOPE scores to include more realistic loop conformations). The final loop model was chosen based 
on the following criteria: loop residues do not clash with bound ceftazidime in the active site, the new 
loop does not form interactions with Arg214, and loop reaches in the cavity near the active site (where 
the “ordered” loop is in the apoenzyme) rather than fully into bulk solvent. All crystallographic waters 
closer than 2.5 Å to the new loop were deleted to avoid possible clashes.  
The “disordered” Ω-loop is not seen in the crystal structure of OXA-48 and ceftazidime (lacking 
electron density), and it is therefore predicted to be highly flexible compared to the surrounding 
structural elements. The chosen loop model was validated by measuring Cα-atom RMSF values for 
three 100 ns molecular dynamics simulations and by comparing the calculated fluctuations of the new 
Ω-loop against fluctuations in rest of the protein. The first 10 ns of each simulation were excluded 
from RMSF calculations to allow for system equilibration. RMSF values for each simulation are 
presented in Figure S2, and they indicate that the newly constructed loop region is the most flexible 
part of the protein. Loop flexibility is somewhat exaggerated in simulation 2, as it is observed to move 
into bulk solvent and then move back to the vicinity of the active site.  
 
Figure S2. RMSF measurement for Cα-atoms for the distorted Ω-loop model of OXA-48. RMSF was 
measured from three 100 ns MD simulations and compared against the average RMSF for OXA-48 






Scheme S1. Schematic illustration of the complete hydrolysis reaction in serine β-lactamases.13 After 
the initial Michaelis complex formation, the antibiotic is acylated (1) and a tetrahedral intermediate is 
formed (2), which collapses to give the acylenzyme structure (3). Subsequently, the acylenzyme is 
deacylated forming a second unstable tetrahedral intermediate (4), which collapses to the final 
hydrolysis product (5).  
 
Computational Methods 
After initial preparation, all structures were briefly minimized (1000 and 1000 steps of deepest 
descent and conjugate gradient, respectively) and heated from 50 K to 300 K in 20 ps. After heating, 1 
ns MM MD was run to generate starting structures for umbrella sampling (US) calculations. Classical 
MD simulations were run using Langevin dynamics with a 2 fs timestep constraining all bonds 
involving hydrogen atoms with the SHAKE algorithm. All starting structures were chosen from the 
last 500 ps of the 1 ns run to allow for system equilibration during the first half (starting structures at 
least 50 ps apart). (Tests were also performed using starting structures after at least 50 ns of MM MD, 
see section “Extended MD Simulations: Stability, Loop Conformation and Free Energy Barriers”.)  
All MM MD simulations were performed using a 2 fs timestep, Langevin dynamics with a collision 
frequency of 0.2, and periodic boundary conditions. The SHAKE algorithm was applied for all bonds 
involving hydrogen atoms. QM/MM simulations were performed under the same conditions, but with 
a 1 fs timestep and SHAKE turned off for the QM region. The Amber program package was used for 
all calculations.14 
 
QM/MM Free Energy Calculations 
QM/MM US15, 16 MD simulations were done using two analogous reaction coordinates as for class A 
enzymes: one for describing the proton transfer from DW to the general base, and one for describing 
the nucleophilic attack (Figure S3). The proton transfer reaction coordinate was sampled from 1.0 to 
−1.0 Å, and the nucleophilic attack coordinate from 3.8 to 1.4 Å, both in 0.1 Å increments with a 100 
kcal mol−1 Å−2 force constant. First, US was performed along an approximate (see below) minimum 
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free energy path (MFEP) from AE to TI on the 2D free energy surface (FES) in 33 US windows, and 
afterwards sampling along the rest of the surface was performed using these windows as starting 
points (altogether 525 US windows). US was first done for in each window for 2 ps for equilibration, 
followed by a further 20 ps along the approximate MFEP and a further 2 ps in all other windows. This 
approach should ensure enough sampling near the true reaction path, whilst minimizing sampling in 
high energy regions on the FES. US was done for four different starting structures taken from a 1 ns 
MM/MD run. The QM region consists of the deacylating water (DW), KCX, and a part of the 
covalently bound drug (38 atoms, Figure S4), and DFTB317 was used as the QM method with a 1 fs 
timestep. Covalent bonds between the QM and MM regions were treated using the hydrogen link 
atom scheme implemented in sander (Amber). A one-sided restraint was added for the ester bond 
between Ser70 and the substrate to ensure it does not elongate above 1.6 A (Figure S4). All US results 
were analysed and FESs constructed using WHAM18 with 21 and 25 bins for the proton transfer and 
nucleophilic attack coordinates respectively, with a convergence criterium set to 1x10−13. Calculations 
were done for four snapshots, and the overall energy barriers were obtained by combining all 
sampling from these four US calculations into one WHAM calculation. True MFEPs on the FESs 
were calculated using the Minimum Energy Pathway Analysis for energy landscapes (MEPSA) 
code.19  
 
Figure S3. Illustration of the reaction coordinates used in umbrella sampling describing the changed 
in bonding during the tetrahedral intermediate formation. The proton transfer coordinate is defined 
with dark blue arrows as the difference d1-d2 (d[Lys73:O, DW:H] – d[DW:O, DW:H]). The 
nucleophilic attack coordinate is depicted as the red arrow, distance d3 (d[DW:O, CTZ:C]).   
 
The approximate minimum energy path for OXA-48 variants was constructed based on calculated 
class A deacylation surfaces, and consists of 33 initial US windows (PT=proton transfer, 
NA=nucleophilic attack): 
PT 1.0 0.9 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.7 0.6 
NA 3.8 3.7 3.6 3.5 3.4 3.3 3.2 3.1 3.0 2.9 2.8 2.7 2.6 2.5 2.4 
 
PT 0.5 0.4 0.3 0.2 0.1 0.0 -0.1 -0.2 -0.3 -0.4 -0.5 -0.6 -0.7 






PT -0.8 -0.8 -0.9 -1.0 
NA 1.5 1.4 1.4 1.4 
 
 
Figure S4. QM region used in US calculations; QM atoms in red, MM atoms in black; location of 
link atoms indicated with squiggly lines. The ester bond in blue was restrained to be less than (or 
equal to) 1.6 A during US to avoid sampling the next step. 
 
Free Energy Surfaces – short sampling 
Free energy barriers for deacylation (Δ‡Gcalc values) in Table 1 (main manuscript) were calculated by 
sampling 20 ps near the approximate minimum energy path and 2 ps elsewhere on the free energy 
surface (as described above, from now on referred to as 20 + 2 ps sampling). The 2 ps ‘equilibration’ 
sampling in each window (prior to the US used for the free energy analysis reported in Table 1) was 
also used directly for the calculation of free energy surfaces using WHAM (as detailed above). 
Notably, Δ‡Gcalc values based on the 2 ps surfaces (without equilibration) do not largely differ from 
the 20 + 2 ps results (largest difference 0.5 kcal/mol; see Table S1), and show the same consistent 
difference in deacylation rates between different OXA-48 variants.  
Table S1. Deacylation free energy barriers calculated from 2 ps sampling. All values in kcal/mol, 
standard deviations in parenthesis. 








OXA-48 NH 12.4 (0.8) 18.5 (1.0) >20a 
OXA-48 
R214S - 6.9 (0.5) 14.0 (1.4) >20
a 
OXA-163 8 7.2 (0.3) 15.7 (1.4) N/A 
OXA-181 ND 11.0 (1.9) 17.7 (0.6) - 
OXA-181 
R214S - 6.4 (0.3) N/A - 
NH = No hydrolysis detected. ND = Not determined. N/A = Not applicable (Ω-loop not present). 






For the QM/MM MD umbrella sampling simulations, the semi-empirical DFTB3 method was used. 
The free energy surface indicates a concerted mechanism with a barrier lower than that expected from 
experiment. Here, we perform more accurate DFT calculations (and ab initio single-point energy 
calculations) using a small gas-phase system representing the quantum region used in our QM/MM 
simulations (Figure S5). Transition states (TS) were optimised on both the M06-2X/6-31+G(d)21, 22 
and BLYP/6-31G+(d)23, 24 levels using the QST3 algorithm as implemented in Gaussian0925. 
UltraFine integration grid was used for all calculations.  
 
Figure S5. Left: Small molecule model representing the QM region used in benchmarking 
calculations. Right: M06-2X/6-31+G(d) optimized transition state of the small molecule model. Red 
arrows: proton transfer reaction coordinate, blue arrow: nucleophilic attack reaction coordinate. 
TSs were characterized by a frequency calculations, and the TS on the M06-2X level corresponded to 
one imaginary frequency (-293.2677), whilst TS optimized using the BLYP functional yielded two 
imaginary frequencies (-107.3119 corresponding to the reaction, and one at -1.8944, corresponding to 
an overall bend/twist motion). IRC calculations starting from the M06-2X TS structure were 
performed in both directions to obtain the reactant and product minima, and the end structures where 
further optimised on the M06-2X/6-31+G(d) level. Reactants and products were optimised also with 
BLYP (starting from the M06-2X optimised structures). The reaction coordinate values of the TSs 
indicate that the reaction proceeds through a concerted mechanism, similar to that predicted by the 
DFTB3/ff14SB free energy surface (Table S2). Calculated activation energies (Table S2) indicate that 
DFTB3 significantly underestimates this value. RI-SCS-MP2/aug-cc-pVTZ26-28 single-point energies 
were calculated on the M06-2X optimized structures using Orca 4.229, 30 (using the RIJK 
approximation and aug-cc-pVTZ/C and aug-cc-pVQZ/JK auxiliary basis sets31). DFTB3 single-point 
energies were calculated for BLYP optimized structures using sqm as part of the Amber package.15 
Comparison of these RI-SCS-MP2/aug-cc-pVTZ and DFTB3 activation energies shows that, based on 







Table S2. Location of the transition state for M06-2X and BLYP optimized small QM model (Figure 
S5), and calculated activation energy barrier. NA RC = nucleophilic attack reaction coordinate, PT 
RC = proton transfer reaction coordinate.  
Method NA RC (Å) PT RC 
(Å) 
Δ‡Gcalc (kcal/mol) 
M06-2X/6-31+G(d) 1.97 -0.35 14.85 
RI-SCS-MP2/aug-cc-pVTZa - - 16.63 
BLYP/6-31+G(d) 1.83 -0.51 15.53 
DFTB3b - - 9.65 
DFTB3/ff14SB FES (OXA-48)c 1.7 -0.5  
a Energy difference from single-point energies on M06-2X/6-31+G(d) optimized AE and TS structures. 
b Energy difference from single-point energies on BLYP/6-31+G(d) optimised AE and TS structures; A 
transition state could not be optimized in the gas-phase with DFTB3 as no saddle point is indicated between the 
AE minimum and the tetrahedral intermediate. 
c For reference, the approximate TS location obtained from the QM/MM free energy surface (see Figure 2) is 
indicated.  
 
For the purpose of comparing the in-enzyme energy surface shape and energies, a QM/MM potential 
energy surface was obtained. Starting from a snapshot of one OXA-48 US simulation in the window 
corresponding to the (approximate) transition state, a potential energy surface (PES) was calculated 
for the deacylation reaction. The LBFGS method was used for minimization (with convergence 
criterium of 0.01 mol-1 Å-1 for energy gradients). Residues further than 5 Å away from ceftazidime 
were restrained with a restraint weight of 50 kcal mol-1 Å-2 (to avoid discontinuities). Single-point 
energy corrections were calculated by taking the difference in the QM region energies calculated at 
the M06-2X/def2-TZVP level (using the RIJK approximation with def2/JK auxiliary basis set) with 
Orca 4.2 and the DFTB3 level. (QM-MM interaction terms were thus calculated with DFTB3.)  
 
Figure S6. Left: Potential energy surface for ceftazidime deacylation calculated with DFTB3; energy 
at -0.5,1.6 (location of the free energy surface TS) is 13.4 kcal/mole. Right: DFTB3 potential energy 
surface with M06-2X/def2-TZVP energy corrections; approximate TS at -0.3,1.9 is 19.4 kcal/mole. 




Mulliken Charge Calculations  
Mulliken charges for the QM region were calculated from extended US in both acylenzyme and 
tetrahedral intermediate minima from one individual US free energy surface. Charge values were 
calculated as an average from 1000 frames over 20 ps (i.e. snapshots recorded every 20 fs). Mulliken 
charges are presented for OXA-48 (both ordered and disordered Ω-loop), OXA-48 Arg214Ser, and 
OXA-163. All four models show the same trend, where largest charge variations are observed for the 
atoms that directly take part in deacylation or are near the reactive parts (Figure S7). Mulliken charges 
were recorded for the QM atoms in both the enzyme environment and in the gas-phase. For the gas-
phase charge calculations, each frame of the QM/MM MD trajectory was extracted as a separate 
structure and pseudo-minimized (minimization with 0 steps) to obtain the QM region with link atoms. 
Subsequently, a single-point QM calculation was done for each QM region structure using sqm (as 
implemented in Amber) to obtain the Mulliken charges. The results on key atoms are reported in 
Tables S3-S5. 
  
Figure S7. QM region with link atoms (in green). Atom names shown for selected heavy atoms, whose 
Mulliken charges were recorded during QM/MM MD. 
 
Table S3. Mulliken charges for WT OXA-48 and ceftazidime. 
QM atom 
Enzyme QM region only 
QAC QTI ΔQ
TI-
AC QAC QTI 
ΔQTI-
AC 
KCX-OQ1 -1.01 -0.59 0.41 -0.93 -0.56 0.36 
KCX-OQ2 -0.91 -0.80 0.11 -0.86 -0.74 0.12 
KCX-C 0.98 0.83 -0.15 0.94 0.81 -0.13 
DW-O -0.85 -0.76 0.09 -0.84 -0.73 0.11 
CTZ-O -0.65 -1.0 -0.35 -0.56 -0.92 -0.37 
CTZ-C 0.71 0.91 0.20 0.69 0.89 0.20 





Table S4. Mulliken charges for WT OXA-48 with a ‘disordered’ Ω-loop and ceftazidime. 
QM atom 
Enzyme QM region only 
QAC QTI ΔQ
TI-
AC QAC QTI 
ΔQTI-
AC 
KCX-OQ1 -1.03 -0.64 0.39 -0.92 -0.59 0.32 
KCX-OQ2 -0.95 -0.85 0.10 -0.87 -0.76 0.11 
KCX-C 1.00 0.87 -0.14 0.93 0.82 -0.11 
DW-O -0.89  -0.75 0.14 -0.88 -0.71 0.17 
CTZ-O -0.69 -0.99 -0.30 -0.60 -0.91 -0.31 
CTZ-C 0.74 0.91 0.17 0.71 0.88 0.18 
CTZ-OG -0.33 -0.57 -0.25 -0.33 -0.58 -0.25 
 
Table S5. Mulliken charges for R214S OXA-48 and ceftazidime. 
QM atom 
Enzyme QM region only 
QAC QTI ΔQ
TI-
AC QAC QTI 
ΔQTI-
AC 
KCX-OQ1 -0.94 -0.59 0.35 -0.89 -0.56 0.33 
KCX-OQ2 -0.89 -0.78 0.11 -0.86 -0.74 0.12 
KCX-C 0.96 0.83 -0.14 0.94 0.81 -0.13 
DW-O -0.93 -0.79 0.14 -0.87 -0.76 0.11 
CTZ-O -0.69 -1.00 -0.31 -0.56 -0.88 -0.32 
CTZ-C 0.73 0.93 0.20 0.70 0.91 0.21 
CTZ-OG -0.32 -0.60 -0.27 -0.34 -0.62 -0.28 
 
Table S6. Mulliken charges for OXA-163 and ceftazidime. 
QM atom 
Enzyme QM region only 
QAC QTI ΔQ
TI-
AC QAC QTI 
ΔQTI-
AC 
KCX-OQ1 -0.94 -0.61 0.33 -0.90 -0.59 0.32 
KCX-OQ2 -0.89 -0.79 0.10 -0.86 -0.75 0.11 
KCX-C 0.97 0.84 -0.13 0.94 0.82 -0.12 
DW-O -0.92 -0.82 0.10 -0.88 -0.81 0.06 
CTZ-O -0.67 -1.00 -0.33 -0.57 -0.90 -0.33 
CTZ-C 0.73 0.92 0.20 0.70 0.90 0.21 










Clustering of the acylenzyme was done based on five 50 ns MD simulations (1250 frames/simulation) 
per acylenzyme model (OXA-48 with (dis)ordered Ω-loop, OXA-48 Arg214Ser, OXA-163). All MD 
simulations were combined into one clustering calculation by stripping all solvent molecules and parts 
of the protein that did not match between all enzymes (e.g β5 - β6 loop in OXA-48). Trajectories were 
aligned based on Cα-atoms of 12 residues near the active site (CTZ, Thr71-Pro75, Ser118, Lys208-
Tyr211, Lys218), and the substrate orientations were clustered into four clusters (using a sieve of 20) 
based on the RMSD of CTZ heavy atoms. The clustering analysis does not show any significant 
differences between the different enzyme models near the formed ester bond and the electrophilic 
carbon, but larger deviations between enzymes are seen for the oxyimino and thiazole groups. As 
depicted in Figure S8, OXA-48 with a newly constructed Ω-loop is seen to sample one orientation not 
observed for other enzymes (green cluster), as it has more space in the active site for substrate 
movement due to loop distortion.  
 
 
Figure S8. Acylenzyme orientations during extended MD from k-means clustering analysis. 
Representative structures (cluster centroids) are shown of the largest clusters (most sampled 
orientations) for OXA-48 (grey), OXA-163 (magenta), OXA-48 Arg214Ser (cyan), and OXA-48 with 







Oxyanion Hole Hydrogen Bond Distances 
 
Figure S9. The oxyanion hole, formed by backbones of Ser70 (the AE) and Tyr211, stabilises the 
formation of a tetrahedral intermediate (hydrogen bonds highlighted in violet). 
Because oxyanion hole interactions are known to stabilise the forming tetrahedral intermediate 
structure, distances of these hydrogen bonds (formed by the backbones of Ser70 in the ceftazidime 
acylenzyme and Tyr211, Figure S9) were measured both from five 50 ns MM MD simulations per 
enzyme (for the acylenzyme), and from four 20 ps QM/MM MD simulations per enzyme (for the 
tetrahedral intermediate). Distance measurements are presented in Figures S10-S13. Overall, distances 




Figure S10. Hydrogen bond distances between the mainchain of Tyr211 and ceftazidime in the 




Figure S11. Hydrogen bond distances between the mainchain of Ser70 and ceftazidime in the 
oxyanion hole from 50 ns MM/MD (measured from five MD simulations per acylenzyme model). 
 
Figure S12. Oxyanion hole distances between Ser70 backbone and ceftazidime in the tetrahedral 





Figure S13. Oxyanion hole distances between Tyr211 backbone and ceftazidime in the tetrahedral 




Figure S14. Three observed rotamers of Leu158. Representative structures are highlighted for 
structures where the C-Cα-Cβ-Cγ dihedral angle (χ1) is approximately 50° (g+; cyan), 170° (t; grey), 






Figure S15. Leu158 C-Cα-Cβ-Cγ dihedral (χ1) values measured from five 50 ns MD simulations for 
each enzyme. Three different rotamers are observed for each enzyme during MD simulations: around 
50°, 170° and 290° (g+, t, and g-, respectively).  The orientation found in the apoenzyme corresponds 






Extended MD Simulations: Stability, Loop Conformation and Free Energy 
Barriers 
To further inspect the stability of the simulation systems and check for possible of conformational 
changes in the studied OXA-48 variants, we ran five additional independent 120 ns MD simulations 
each for the acylenzymes of OXA-48, OXA-163 and OXA-48 R241S (in binding mode 1 and with the 
ordered Ω-loop). Measurement of the RMSD for Cα-atoms (excluding the first flexible five residues 
in the N terminus) indicates that all three systems are stable (Figure S15). 
 
Figure S16. Cα-RMSD of five 120 ns MM MD simulations for OXA-48 (left), OXA-48 Arg214Ser 
(middle), and OXA-163 (right) 
. 
The β5 – β6 loop movement in OXA-48 and OXA-48 R214S was further inspected from the 120 ns 
MD simulations by clustering the sampled loop orientations based on Cα-RMSD. All five OXA-48 
trajectories and five OXA-48 R214S trajectories were aligned on Cα-atoms of residues 29-211 & 219-
265 (excluding five residues from the N-terminal end), and then divided in 5 clusters based on Cα-
RMSD of the β5 – β6 loop (residues 212-218). Clustering was performed with the k-means algorithm 
as implemented in cpptraj with a sieve of 20. For the majority of simulation time, the β5 - β6 loop in 
OXA-48 and in OXA-48 R214S sample the same conformational space (70% and 76% in clusters 1-3 
for OXA-48 and OXA-48 R214S, respectively, with populations ≥ 20% for each enzyme/cluster). 
Although the remainder of the time (30% and 23% for OXA-48 and OXA-48 R214S, respectively) 
the loop conformations are slightly different, it is clear that the mutation does not lead to a significant 




Figure S17. Clustering of the β5 - β6 loop (k-means clustering based on loop backbone RMSD after 
alignment on the rest of the protein, into 5 clusters) of 5x 120ns simulations of both OXA-48 and 
OXA-48 R214S. Loop carbons are coloured by cluster as follows: 1 green, 2 magenta, 3 yellow, 4 
cyan and 5 orange. Ceftazidime acylenzyme and the Ω-loop are also shown, for reference.  
 
Additionally, we performed one QM/MM (DFTB3/ff14SB) US simulation per enzyme variant by 
taking a starting structure from the 120 ns MD simulations. To make the calculated energetics 
comparable with the ones calculated for starting structures taken from 1 ns MD simulation, the 
structure for each variant was chosen so that Leu158 conformation and active site hydration replicate 
the ones observed in the original starting structures (i.e. Leu158 dihedral is 50° for OXA-48, and 170° 
for OXA-48 Arg214Ser and OXA-163). Results from 2 ps QM/MM US simulations, using the same 
procedure as applied previously, indicate similar free energies are obtained as with snapshots from the 
initial short 1 ns MD simulation (Table S7).  
 
Table S7. Free energy barriers calculated with DFTB3/ff14SB umbrella sampling from extended MD 
snapshots.    
Enzyme Time Δ‡Gcalc 
(kcal/mol) 
OXA-48 50 ns 12.42 
OXA-48 
R214S 120 ns 7.45 
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